Caxton Associates LP Charles River Laboratories International, Inc. Transaction History

Caxton Associates LP

  • $2.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $1.53 Million - $2.07 Million
7,976 New
7,976 $1.61 Million
Q2 2022

Aug 15, 2022
BUY
$204.13 - $302.4 $317,422 - $470,231
1,555 New
1,555 $333,000
Q4 2018

Feb 14, 2019
SELL
$105.09 - $137.23 $240,971 - $314,668
-2,293 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $257,068 - $308,500
2,293 New
2,293 $309,000

Others Institutions Holding CRL

# of Institutions
698
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email